Metabolic

Tirzepatide

An approved medicine. This listing is not a prescription or a dosing guide.

A dual GIP and GLP-1 receptor agonist used in approved prescription medicines for type 2 diabetes and chronic weight management in eligible patients. It improves blood glucose regulation and can produce substantial weight loss.

Vial size

CA$68

Estimated retail midpoint, CAD

• Code BC-17
• Form Research vial
• Category Metabolic

Research-use only. Not for human or veterinary administration. Availability depends on applicable regulations, including in Canada. Prices are estimates, not verified market averages. Descriptions are informational and do not imply Health Canada approval or proven clinical effectiveness. Many listed compounds are investigational or not authorized for human use in Canada.